PFE – Pfiser Inc, a global bio-pharmaceutical company, has been on a downtrend since November 2015. Analysts believe the stock is undervalued, especially post the announcement of FDA approval of the drug – Xeljanz XR (tofacitinib citrate)
PFE – Pfiser Inc | ||
Fundamentals | Previously closed at | 30.01 |
Day’s high | 30.08 | |
Day’s low | 29.51 | |
P/E ratio | 24.25 | |
EPS | 1.24 |
Analysts opinion | PFE has a PEG ratio of 2.42, P/S of 3.79 and a P/B of 2.77. Currently, its forward P/E is 12.15, lower than the stocks in the SPX at 17. |
Sentiments | Xeljanz XR is the first and only oral treatment for RA (Rheumatoid arthritis), which is a chronic, inflammatory autoimmune disease that causes a range of symptoms, including pain and swelling in the joints, particularly those in the hands, feet and knees. This drug is approved in more than 45 countries in the world, and PFE has huge potential for the drug. According to statistics, 1.3 million Americans have RA, and out of every 100,000 people, 41 are diagonised with RA every year. |
Despite the announcement, the stock had lower sentiments yesterday. Analysts believe that eventually, the market will rise to take into consideration the increased potential of the firm due to FDA approval. | |
Revenue Prediction | The estimize consensus EPS for Q1 2016 is $0.55 and the revenue for the same period is $12,064 million |
Social Pulse | The stock has 43% lower social chatter than usual. |
ELY – Callaway Golf Co deals with designing, manufacturing, and selling of golf clubs, golf balls, golf bags and other related accessories. It saw a surge in its prices in the last trading session, and analysts believe that it will enjoy further positive sentiments in the near future.
ELY – Callaway Golf Co | ||
Fundamentals | Previously closed at | 8.83 |
Day’s high | 8.89 | |
Day’s low | 8.68 | |
P/E ratio | 51.94 | |
EPS | 0.17 |
Analyst opinion | ELY has a high PEG ratio(2.04), and a P/B of 1.98, a P/C of 15.94, and 80% Analyst Buy opinion. |
Sentiments | Prices for ELY surged after an announcement yesterday that TopGolf Entertainment Group, a company in which it owns a stake of 18.5% has obtained significant stock investment from Providence Equity Patterns. |
The stock has a “Buy” rating from many brokers. According to a report, this transaction represents more than 300% gains on ELY’s investment in TopGolf. Also, the upcoming Golf season may have positive sentiments for ELY | |
Revenue Prediction | The Estimize prediction for Q1 2016 is $0.4 EPS and revenue of $285.93 |
Social Pulse | The stock has 100% higher social chatter than usual |